http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9709819-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_169f37b7ac0c2f08a26de271d108cdc1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-301
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1997-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477f8c3a0ab7cb7bd667a35ca3534ab7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13fcb5d458dc3eb189623108a2c23924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32fd11714391cdf40dbdf0898126ffcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7bc7e9a686fbae8d277b00b651cfd5e
publicationDate 2000-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9709819-A
titleOfInvention Process for treating cancer using naaladase inhibitors
abstract Invention Patent: <B> "PROCESSES FOR TREATING CANCER USING NAALADASE INHIBITORS" <D>. The invention relates to dipeptidase inhibitors and, more particularly, to new methods of using phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives to inhibit the N-Acetylated α-Linked Acid Dipeptidase (NAALADase) enzyme activity, and to treat prostate disease, especially using the compounds of the present invention for inhibiting the growth of prostate cancer cells.
priorityDate 1996-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969

Total number of triples: 32.